DE69634092D1 - Herstellung von antikörpern - Google Patents

Herstellung von antikörpern

Info

Publication number
DE69634092D1
DE69634092D1 DE69634092T DE69634092T DE69634092D1 DE 69634092 D1 DE69634092 D1 DE 69634092D1 DE 69634092 T DE69634092 T DE 69634092T DE 69634092 T DE69634092 T DE 69634092T DE 69634092 D1 DE69634092 D1 DE 69634092D1
Authority
DE
Germany
Prior art keywords
antibodies
selected part
source
immunizing
administering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69634092T
Other languages
English (en)
Other versions
DE69634092T2 (de
Inventor
Randell Bradwell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Binding Site Group Ltd
Original Assignee
Binding Site Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9522554.6A external-priority patent/GB9522554D0/en
Priority claimed from GBGB9615578.3A external-priority patent/GB9615578D0/en
Application filed by Binding Site Ltd filed Critical Binding Site Ltd
Publication of DE69634092D1 publication Critical patent/DE69634092D1/de
Application granted granted Critical
Publication of DE69634092T2 publication Critical patent/DE69634092T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69634092T 1995-11-03 1996-10-30 Herstellung von antikörpern Expired - Lifetime DE69634092T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9522554.6A GB9522554D0 (en) 1995-11-03 1995-11-03 Improvements in and relating to the production of antibodies and test kits incorporating them
GB9522554 1995-11-03
GB9615578 1996-07-24
GBGB9615578.3A GB9615578D0 (en) 1996-07-24 1996-07-24 Improvements in and relating to the treatment of disorders which require the administration of substances which elicit an immune response
PCT/GB1996/002638 WO1997017372A1 (en) 1995-11-03 1996-10-30 Production of antibodies, and medical uses involving antibodies

Publications (2)

Publication Number Publication Date
DE69634092D1 true DE69634092D1 (de) 2005-01-27
DE69634092T2 DE69634092T2 (de) 2005-12-08

Family

ID=26308046

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69634092T Expired - Lifetime DE69634092T2 (de) 1995-11-03 1996-10-30 Herstellung von antikörpern

Country Status (8)

Country Link
US (1) US8133744B1 (de)
EP (1) EP0862584B1 (de)
JP (1) JP4053596B2 (de)
AT (1) ATE285417T1 (de)
AU (1) AU7320096A (de)
DE (1) DE69634092T2 (de)
ES (1) ES2233980T3 (de)
WO (1) WO1997017372A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0862584B1 (de) 1995-11-03 2004-12-22 The Binding Site Limited Herstellung von antikörpern
US8642743B2 (en) * 2004-04-06 2014-02-04 Affibody Ab Method for reducing the immune response to a biologically active protein
GB0501741D0 (en) 2005-01-27 2005-03-02 Binding Site The Ltd Antibody
GB0608444D0 (en) 2006-04-27 2006-06-07 Binding Site The Ltd Dialysis
GB0801609D0 (en) * 2008-01-29 2008-03-05 Binding Site The Ltd Hevylite diagnostic stain
GB0914535D0 (en) 2009-08-19 2009-09-30 Binding Site Group The Ltd Prognosis assay
GB201001950D0 (en) 2010-02-05 2010-03-24 Binding Site Group The Ltd Infection prognostic assay
GB201001946D0 (en) 2010-02-05 2010-03-24 Binding Site Group The Ltd Cancer prognostic assay
GB2478520A (en) 2010-03-02 2011-09-14 Binding Site Group Ltd Kidney prognostic assay
GB201004442D0 (en) 2010-03-17 2010-05-05 Binding Site Group The Biomarker
GB201012049D0 (en) 2010-07-19 2010-09-01 Binding Site Group The Ltd Competition assay
GB201117172D0 (en) 2011-10-05 2011-11-16 Binding Site Group The Ltd Diabetes
GB201121265D0 (en) 2011-12-12 2012-01-18 Binding Site Group The Ltd Assay
GB201603291D0 (en) 2016-02-25 2016-04-13 Binding Site Group The Ltd Antibodies
GB201708262D0 (en) 2017-05-23 2017-07-05 Binding Site Group Ltd Assay for plasma cell associated disease
JP6982226B2 (ja) 2017-07-06 2021-12-17 日東紡績株式会社 抗ヒトＩｇＧ４モノクローナル抗体、およびその抗体を利用したヒトＩｇＧ４測定試薬
BR112021022468A2 (pt) 2019-05-10 2022-01-04 The Binding Site Group Ltd Calibrador de espectrometria de massa
GB201906599D0 (en) 2019-05-10 2019-06-26 Binding Site Group Ltd Mass spectrometry calibrator

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1587193A (en) * 1976-08-25 1981-04-01 Univ Birmingham Process for preparation of antisera
JPH01501476A (ja) * 1986-10-09 1989-05-25 ネオルックス　コーポレイション 抗体、抗体断片、ホルモン並びに他の標的剤、およびそれらの配合体を標的とする改良方法
US4983530A (en) * 1988-01-29 1991-01-08 E. I. Du Pont De Nemours And Company Sandwich immunoassay for determination of total monoclonal IGG
US5585250A (en) * 1993-08-20 1996-12-17 The United States Of America As Represented By The Department Of Health & Human Services Dampening of an immunodominant epitope of an antigen for use in plant, animal and human compositions and immunotherapies
EP0862584B1 (de) 1995-11-03 2004-12-22 The Binding Site Limited Herstellung von antikörpern

Also Published As

Publication number Publication date
US8133744B1 (en) 2012-03-13
JP4053596B2 (ja) 2008-02-27
ATE285417T1 (de) 2005-01-15
ES2233980T3 (es) 2005-06-16
DE69634092T2 (de) 2005-12-08
WO1997017372A1 (en) 1997-05-15
AU7320096A (en) 1997-05-29
JP2001501579A (ja) 2001-02-06
EP0862584B1 (de) 2004-12-22
EP0862584A1 (de) 1998-09-09

Similar Documents

Publication Publication Date Title
DE69634092D1 (de) Herstellung von antikörpern
PT752876E (pt) Anticorpos monoclonicos que se conectam com o percursor antigeneo de rejeicao de tumores mage-1, mage-1 recombinante, e peptidos imunogenicos derivados de mage-1
DE69733960D1 (de) Verwendung von antikörpen gegen cd45ro leukozytenantigen zur immunmodulation
DE69429095T2 (de) Humanisierte antikoerper
DK1375520T3 (da) Apoptose induceret af monoklonalt antistof anti-Her2
ES2106195T3 (es) Anticuerpo igg aglicosilado anti cd3.
DE69529649T2 (de) Anti-egfr einkettige fvs und anti-egfr antikoerper
DK0673255T3 (da) Monoklonale antistoffer, som specifikt binder til vaskulært tumorendotel, og anvendelser deraf
DE68924773D1 (de) Monoklonale antikörper gegen den bereich der leichten kette von menschlichem faktor xii sowie methoden zu deren herstellung und verwendung.
DE3650032T2 (de) Anticytomegaloviraler menschlicher monoklonaler antikörper und dessen herstellung.
JPS6463393A (en) Monoclonal antibody
SE8103198L (sv) Forfarande for framstellning av antikroppar
KR900701318A (ko) 항-사람 고분자량- 흑색종 관련 항원에 대한 항-이디오 타입 항체
ATE123066T1 (de) Monoklonale antikörper und herstellung eines impfstoffes gegen menschliche krebsantigene durch immunisierung mit menschlichem und tierischem mucin und mit synthetischen gluciden- trägerkonjugaten.
FI885169A0 (fi) Monoklonaalinen vasta-aine, joka tunnistaa N-asetyylineuramiinihapon -järjestyksessä, sen käyttö ja sitä tuottava hybridooma
KR890016165A (ko) 수도모나스 아에루기노사(Pseudomonas aeruginosa)에 대한 모노클로날 항체, 이의 제조방법 및 용도
Storch et al. Specificity of monoclonal anti-human insulin antibodies
ATE125305T1 (de) Monoklonale antikörper von ratten gegen menschliche antigene und verfahren zu deren herstellung.
Reid et al. Extrinsic Cotton Effects in Hapten—Carrier and Hapten—Antibody Interactions
WO2003016353A1 (en) Anti-ciguatoxin monoclonal antibody
DE59207362D1 (de) Monoklonale Antikörper gegen den Plasmin-Antiplasmin Komplex, Verfahren zu ihrer Herstellung sowie ihre Verwendung
EA200200730A1 (ru) Способ идентификации веществ, имитирующих эпитопы млекопитающих
AU653332B2 (en) Synthetic peptides which contain sequences from factor VIIa, and the use thereof
Tsunoo et al. Effect of haptoglobin on immunological activity of hemoglobin
EP0450573A3 (de) Antikörper für die Behandlung und die Diagnose von Pseudomonas aeruginosa Infektionen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BINDING SITE GROUP LTD., BIRMINGHAM, GB